Tag Archives: products

Clinical Development: The Clinical Trial Protocol


Dr Michael Silverman, principal at BioStrategics Consulting Ltd, initiates a discussion this week on the Clinical Trial Protocol. The protocol to test one’s product, to confirm or reject a specific hypothesis, is key in the Clinical Development Plan and in … Continue reading

Posted in Clinical, Clinical studies, clinical trials | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

Clinical Trials: The Clinical Development Plan Part 2


Dr Michael Silverman, principal at BioStrategics Consulting Ltd, continues the discussion this week on the formulation of a Clinical Development Plan. This is a vital road map defining how one’s product will be developed through a series of clinical trials … Continue reading

Posted in Clinical, Clinical studies, clinical trials | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Clinical Trials: The Clinical Development Plan Pt 1


Dr Michael Silverman, principal at BioStrategics Consulting Ltd, talks about a second important strategic element of pharmaceutical development in this blog, and that is, the formulation of a Clinical Development Plan. This is a vital road map defining how the … Continue reading

Posted in Clinical, Clinical studies, clinical trials | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

BioStrategics Consulting Ltd Introduces its President and Senior Clinical Development Consultant, Michael H. Silverman, MD, FACP.


BioStrategics Consulting Ltd provides its services through its President and Senior Clinical Development Consultant, Michael H Silverman, MD, FACP. Dr Silverman received his medical education at the University of Chicago Pritzker School of Medicine and is doubly Board-Certified in Internal … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment